RxDoctor Payments Data

Pratima Sharma

Gastroenterology · Ann Arbor, MINPI 1700808862

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,520 of the $5,676 with a category attached, or 97.2%. Mallinckrodt Hospital Products Inc. accounts for 97.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $5,520 and has fallen 99.7% since, to $19 in 2021.

$5,676in general payments, 2019–2025

Across 4 payments — averaging $1419.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$6K
  • Mallinckrodt Enterprises LLC$73
  • Astellas Pharma US Inc$65
  • Pfizer$19
$180,211in research payments, 2019–2025

Across 24 payments — averaging $7508.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$99K
  • Mallinckrodt Enterprises LLC$71K
  • Mallinckrodt Hospital Products Inc.$10K

What the payments were for

  • Consulting fees$5,52097%
  • Food & beverage$912%
  • Education$651%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,676 in reported general payments places this provider in the 70th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$13,205
Medicare patients
70
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin18$54,179
Tacrolimus160$21,933
Ursodiol79$14,400
Cyclosporine ModifiedCyclosporine, Modified39$8,756
Entecavir26$7,519
Mycophenolate Mofetil25$1,469
Tenofovir Disoproxil Fumarate13$417
Prednisone26$299
Omeprazole24$250
Spironolactone16$228
Furosemide19$227

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →